Revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
IGC Pharma, Inc. (IGC)
Price—Loading quote
Net income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Free cash flow
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Total cash / debt
CashTotal debt
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Financial statements
| 2025 · Dec 31 | 2025 · Mar 31 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $869,000 | $1.3M | $1.3M | $911,000 | $289,000 | $898,000 | $4.1M | $5.1M | $2.2M | $580,372 | $6.4M | $7.7M | $2.3M | $8.0M | $4.2M | $4.1M |
| Gross profit | $297,000 | $619,000 | $733,000 | $442,000 | $194,000 | $113,000 | $115,000 | $132,000 | $82,000 | $218,237 | $843,294 | $579,689 | $381,596 | $1.5M | −$618,429 | $159,264 |
| Gross margin | 34.18% | 48.70% | 54.50% | 48.52% | 67.13% | 12.58% | 2.82% | 2.58% | 3.74% | 37.60% | 13.25% | 7.55% | 16.79% | 19.09% | −14.73% | 3.91% |
| Research & development | $3.9M | $3.7M | $3.8M | $3.5M | $2.3M | $929,000 | $1.0M | $1.3M | $137,000 | — | — | — | — | — | — | — |
| Operating expenses | $8.0M | $8.1M | $10.5M | $12.0M | $15.6M | $8.8M | $7.0M | $4.8M | $1.9M | $2.3M | $3.7M | $4.9M | $2.9M | $4.0M | $6.9M | $16.0M |
| Operating income | −$7.7M | −$7.4M | −$9.8M | −$11.6M | −$15.4M | −$8.7M | −$6.9M | −$4.6M | −$1.8M | −$2.1M | −$2.9M | −$4.3M | −$2.5M | −$2.5M | −$7.5M | −$15.9M |
| Operating margin | −891.25% | −585.84% | −728.48% | −1,270.14% | −5,338.41% | −971.49% | −168.57% | −90.75% | −81.58% | −353.98% | −45.64% | −56.54% | −111.20% | −30.93% | −178.87% | −389.95% |
| EBITDA | −$7.4M | −$6.8M | −$9.2M | −$10.9M | −$14.8M | −$8.2M | −$6.7M | −$4.6M | −$1.8M | −$1.7M | −$2.2M | −$3.6M | −$1.8M | −$1.8M | −$6.5M | −$15.1M |
| EBITDA margin | −853.97% | −537.21% | −681.12% | −1,198.02% | −5,113.15% | −918.26% | −165.03% | −89.60% | −80.71% | −285.69% | −34.19% | −46.36% | −79.86% | −22.54% | −155.14% | −370.68% |
| Net income | −$4.1M | −$7.1M | −$13.0M | −$11.5M | −$15.0M | −$8.8M | −$7.3M | −$4.1M | −$1.8M | −$1.9M | −$2.8M | −$4.6M | −$3.0M | −$2.3M | −$7.8M | −$20.2M |
| Net profit margin | −477.10% | −560.35% | −966.54% | −1,263.01% | −5,195.85% | −981.18% | −179.64% | −80.08% | −81.44% | −321.74% | −44.11% | −60.08% | −132.97% | −28.05% | −184.59% | −496.84% |
| Basic EPSper basic share | -$0.05 | -$0.09 | -$0.22 | -$0.22 | -$0.30 | -$0.21 | -$0.19 | -$0.13 | -$0.06 | -$0.07 | -$0.17 | -$0.31 | -$0.37 | -$0.32 | -$2.66 | -$13.40 |
| Diluted EPSper diluted share | -$0.05 | -$0.09 | -$0.22 | -$0.22 | -$0.30 | -$0.21 | -$0.19 | -$0.13 | -$0.06 | -$0.07 | -$0.17 | -$0.31 | -$0.37 | -$0.32 | -$2.66 | -$13.40 |
Owners
Reported shareholders
≈5.43%of listed shares
Mukunda Ram5.56M shares · Apr 1, 2026
View holders
| Holder | % owned |
|---|---|
Mukunda Ram | ≈5.43%5.56M shares |
PRINS RICHARD K | ≈1.50%1.54M shares |
GRIMALDI CLAUDIA | ≈1.34%1.37M shares |
Moran James P | ≈1.21%1.24M shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.86%879.39K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.80%814.91K shares |
BlackRock, Inc. | 0.69%703.8K shares |
AdvisorShares Investments LLC | 0.66%678.48K shares |
CITADEL ADVISORS LLC | 0.43%437.32K shares |
VANGUARD FIDUCIARY TRUST CO | 0.41%419.41K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.28%286.61K shares |
STATE STREET CORP | 0.20%200.8K shares |
NORTHERN TRUST CORP | 0.17%170.27K shares |
DEARBORN PARTNERS LLC | 0.12%118.8K shares |
LAWOOD & CO | 0.07%75K shares |
GOLDMAN SACHS GROUP INC | 0.06%65.54K shares |
JANE STREET GROUP, LLC | 0.06%62.61K shares |
TRUIST FINANCIAL CORP | 0.05%48.67K shares |
CITIGROUP INC | 0.04%46.04K shares |
Fisher Asset Management, LLC | 0.04%43.4K shares |
Percentages use 102.42M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 25, 2024Form 4 | Moran James PDirector | BuyCommon Stock · indirect | 588.2K | $0.34 | $200.0K | 942.4K |